The assessment of glycine decarboxylase levels in p53-mutated B-cell lymphoma

Asian J Surg. 2022 Mar;45(3):936-938. doi: 10.1016/j.asjsur.2021.12.032. Epub 2022 Jan 13.

Authors

Ping Fang¹, Xiang-Dong Li²

Affiliations

¹ Department of Blood Transfusion, The First Affiliated Hospital of Shandong First Medical University (Shandong Province Qianfoshan Hospital), Jinan, 250014, Shandong, China.
² Department of Clinical Laboratory, The First Affiliated Hospital of Shandong First Medical University (Shandong Province Qianfoshan Hospital), Jinan, 250014, Shandong, China. Electronic address: lixd03@21cn.com.

PMID: 35033414
DOI: 10.1016/j.asjsur.2021.12.032

No abstract available

Keywords: B-cell lymphoma; Glycine decarboxylase; p53 gene mutation.

Publication types

Letter

MeSH terms

Glycine Dehydrogenase (Decarboxylating)
Humans
Lymphoma, B-Cell* / genetics
Mutation
Tumor Suppressor Protein p53* / genetics

Substances

Tumor Suppressor Protein p53
Glycine Dehydrogenase (Decarboxylating)